Invention Grant
- Patent Title: Phosphinic peptide derivatives for use as MMP-12 inhibitors
-
Application No.: US15774649Application Date: 2016-11-23
-
Publication No.: US10179797B2Publication Date: 2019-01-15
- Inventor: Stéphanie Boudon , Eileen Jackson , Rolf Schuetz , Jürgen Herbert Vollhardt , Peter Wikstroem , Eliane Ursula Wandeler
- Applicant: DSM IP ASSETS B.V.
- Applicant Address: NL Heerlen
- Assignee: DSM IP ASSETS B.V.
- Current Assignee: DSM IP ASSETS B.V.
- Current Assignee Address: NL Heerlen
- Agency: Nixon & Vanderhye P.C.
- Priority: EP15197009 20151130
- International Application: PCT/EP2016/078511 WO 20161123
- International Announcement: WO2017/093093 WO 20170608
- Main IPC: A61Q19/08
- IPC: A61Q19/08 ; A61Q19/00 ; A61K31/675 ; A61K31/662 ; A61K31/67 ; C07C53/18 ; A61K8/55 ; C07F9/6553 ; C07F9/30 ; C07F9/572
Abstract:
This invention relates to compounds that are selective inhibitors of Matrix Metalloprotease-12 (MMP-12), to cosmetic and pharmaceutical compositions containing them, and to their use in the prevention and/or treatment of ailments associated with MMP-12. Formula (I).
Public/Granted literature
- US20180319829A1 PHOSPHINIC PEPTIDE DERIVATIVES FOR USE AS MMP-12 INHIBITORS Public/Granted day:2018-11-08
Information query
